NCT07190664

Brief Summary

This study aims to systematically evaluate the effects of different anesthesia methods on postoperative chronic cough in lung cancer patients undergoing video-assisted thoracoscopic lung resection (VATS), and to clarify the effectiveness and safety of each anesthesia airway management strategy in reducing the incidence of postoperative chronic cough, shortening the duration of cough, alleviating the severity of symptoms, and improving the postoperative quality of life of patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
228

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 17, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 24, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

September 24, 2025

Status Verified

June 1, 2025

Enrollment Period

2 months

First QC Date

September 17, 2025

Last Update Submit

September 17, 2025

Conditions

Keywords

Video-assisted thoracoscopic surgerychronic cough

Outcome Measures

Primary Outcomes (1)

  • The incidence of postoperative chronic cough, cough duration and cough severity score were recorded

    The perioperative follow-up time points were 1 day, 2 days, 3 days, 7 days, 14 days and 1 month after operation. The follow-up time points of postoperative chronic phase were set at 3 months, 6 months and 12 months after operation.

    The perioperative follow-up time points were 1 day, 2 days, 3 days, 7 days, 14 days and 1 month after operation. The follow-up time points of postoperative chronic phase were set at 3 months, 6 months and 12 months after operation.

Study Arms (3)

Single-lumen endotracheal intubation group

ACTIVE COMPARATOR

During the process of general anesthesia, a single-lumen endotracheal tube combined with a bronchial blocker was used to perform pulmonary isolation surgery, thereby meeting the requirements of video-assisted thoracoscopic partial lung resection.sample size:76

Other: Patients were randomly grouped

Double-lumen endotracheal tube group

ACTIVE COMPARATOR

During the general anesthesia process, a double-lumen endotracheal tube was used for lung isolation surgery, thus meeting the requirements of video-assisted thoracoscopic partial lung resection.sample size:76

Other: Patients were randomly grouped

Laryngeal mask group

EXPERIMENTAL

During the general anesthesia procedure, a laryngeal mask was used, and the patient maintained spontaneous breathing for the thoracoscopic partial lung resection surgery.sample size:76

Other: Patients were randomly grouped

Interventions

All patients included in the study, were randomized

Double-lumen endotracheal tube groupLaryngeal mask groupSingle-lumen endotracheal intubation group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • planned wedge resection, segmentectomy or lobectomy;
  • more than 18 years old;
  • American Society of Anesthesiologists (ASA) grade ≤Ⅲ;
  • body mass index (BMI) ≤24 kg/m2;
  • Normal pulmonary function, predicted forced expiratory volume in 1 second (FEV1%) \>50%, resting blood gas analysis showed arterial partial pressure of oxygen (PaO2) ≥75 mmHg and arterial partial pressure of carbon dioxide (PaCO2) \<45 MMHG;
  • Normal cardiac function with ejection fraction (EF) \> 50% of predicted value;
  • Informed consent and signed informed consent form.

You may not qualify if:

  • (1) patients who refuse surgery and/or anesthesia; (2) preoperative pulmonary infection; (3) previous history of ipsilateral surgery or other medical history that may cause extensive pleural adhesions; (4) phrenic nerve palsy on the non-operative side; (5) patients with high risk of preoperative reflux (fasting \<6 hours) or gastroesophageal reflux disease; (6) patients with heart, kidney, liver and other organ dysfunction and surgical contraindications; (7) with severe cognitive, psychological and communication disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Chronic Cough

Condition Hierarchy (Ancestors)

CoughRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 17, 2025

First Posted

September 24, 2025

Study Start

October 1, 2025

Primary Completion

December 1, 2025

Study Completion

December 30, 2025

Last Updated

September 24, 2025

Record last verified: 2025-06